Hypofractionated post-prostatectomy radiotherapy for prostate cancer to reduce toxicity and improve patient convenience: A Phase I/II trial.

This is a multicenter, Phase I/II study of hypofractionated (HypoFX) prostate bed radiation therapy (RT) as salvage or adjuvant therapy. The Phase I portion of this study aimed to identify the shortest dose-fractionation schedule with acceptable toxicity.